Brief: Alligator Bioscience Q4 Operating Loss Narrows To SEK 34.1 Million
Feb 26 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR BIOSCIENCE AB: YEAR-END REPORT JANUARY-DECEMBER
2020
* Q4 OPERATING RESULT, SEK -34.1 MILLION (-59.3).
* Q4 NET SALES, SEK 0.0 MILLION (0.0).
* Q4 RESULT FOR PERIOD, SEK -34.5 MILLION (-59.8).
Source text for Eikon: ID:nWkr5ScxFM
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln